Summary
Metabolic glucose control was followed in 36 patients at 12-month intervals for up to 5 years after a successful combined kidney and segmental duct-occluded pancreas transplantation. All recipients had normal blood glucose levels at each examination. HbA1 values, intravenous glucose tolerance test, C-peptide levels and C-peptide responses to glucagon stimulation were also, on average, within the normal range. Several individual patients had, however, abnormal values for these parameters. At most 46% had abnormal values for HbA1 and intravenous glucose tolerance test, up to 13% showed low C-peptide values and up to 46% of the stimulated C-peptide responses were inadequate at the different intervals. These parameters did not deteriorate with time. This was true both for the whole group of patients as well as for the 6 patients with a 5-year observation time evaluated separately. Despite these abnormalities in glucose metabolism, all patients remained normoglycaemic without need for exogenous insulin up to 5 years after transplantation. The long-term ability of duct-occluded segmental pancreatic grafts to preserve euglycaemia therefore seems to remain intact at least for 5 years.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Dubernard JM, Traeger T, Neyra P, Touraine JL, Tranchant D, Blanc-Brunat N (1978) New method of preparation of a segmental pancreatic graft for transplantation: trials in dogs and in man. Surgery 84: 634–639
Garber AJ, Cryer PE, Santiago JV, Raymond MW, Pagliana AS, Kipnis DM (1976) The role of adrenergic mechanisms in the substrate and hormonal response to insulin-induced hypoglycemia in man. J Clin Invest 58: 7–15
Groth CG, Tydén G, Brattström C, Boman SO, Östman J (1988) Pancreatic transplantation for diabetes mellitus: The Stockhohn experience. Transpl Proc XX; [suppl] 1: 862–865
Gunnarsson R, Klintmalm G, Lundgren G, Wilczek H, Östman J, Groth CG (1986) Deterioration in glucose metabolism in pancreatic transplant recipients given cyclosporine. Lancet 2: 571–572
Holdaas H, Brekke IB, Hartmann A, Fauchald P, Berg KJ, Sødal G, Jervell J, Flatmark, A (1990) Metabolic control in recipients of ductoccluded segmental pancreatic grafts: A four-year follow-up. Transpl Proc 22: 655–656
Landgraf R, Nusser J, Müller W, Landgraf-Leurs MMC, Thurau S, Ulbig M, Kampik A, Lachenmayr B, Hillebrand G, Schleibner S, Illner WD, Abendroth D, Land W (1989) Fate of late complications in type I diabetic patients after successful pancreas-kidney transplantation. Diabetes 38; [suppl] 1: 33–37
Lundbaek K (1962). Intravenous glucose tolerance as a tool in definition and diagnosis of diabetes mellitus. Brit Med J 2: 1507–1511
Nakache R, Tydén G, Groth, CG (1989) Quality of life in diabetic patients after combined pancreas-kidney or kidney transplantation. Diabetes 38: [suppl] 1: 40–42
Nordén G, Nyborg G, Hedman L, Olausson M, Frisk B (1990) Transplantation in patients with diabetic nephropathy. Transpl Int 3: 234–237
Robertson RP, Abid M, Sutherland DER, Diem P (1989) Glucose homeostasis and insulin secretion in human recipients of pancreas transplantation. Diabetes 38; [suppl] 1: 97–98
Sarlund H, Siitonen O, Laakso M, Pyörala K (1987) Repeatibility of C-peptide response in glucagon stimulation test. Acta Endocrinologica 114: 515–518
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Holdaas, H., Brekke, I.B., Hartmann, A. et al. Long-term metabolic control in recipients of combined pancreas and kidney transplants. Diabetologia 34 (Suppl 1), S68–S70 (1991). https://doi.org/10.1007/BF00587623
Issue Date:
DOI: https://doi.org/10.1007/BF00587623